Benjamin Verret

2.2k total citations · 1 hit paper
37 papers, 612 citations indexed

About

Benjamin Verret is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Benjamin Verret has authored 37 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Benjamin Verret's work include Sarcoma Diagnosis and Treatment (14 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Advanced Breast Cancer Therapies (5 papers). Benjamin Verret is often cited by papers focused on Sarcoma Diagnosis and Treatment (14 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Advanced Breast Cancer Therapies (5 papers). Benjamin Verret collaborates with scholars based in France, Italy and United States. Benjamin Verret's co-authors include Jean‐Charles Nault, Jessica Zucman‐Rossi, Fabien Calvo, Andrea Franconi, Éric Letouzé, Alexis Laurent, Camilla Pilati, Jean‐Frédéric Blanc, Julien Caldéraro and Mélanie Letexier and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Benjamin Verret

33 papers receiving 606 citations

Hit Papers

Recurrent AAV2-related insertional mutagenesis in human h... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
    2015 369 citations Benjamin Verret et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Verret France 9 284 202 179 114 107 37 612
Jeannine Lacroix Germany 15 253 0.9× 168 0.8× 490 2.7× 143 1.3× 186 1.7× 25 826
Elizabeth Mroczek‐Musulman United States 13 199 0.7× 82 0.4× 130 0.7× 47 0.4× 50 0.5× 41 523
Ursula R. Sorg Germany 13 254 0.9× 108 0.5× 177 1.0× 54 0.5× 33 0.3× 26 580
M L Veronese United States 15 622 2.2× 432 2.1× 339 1.9× 183 1.6× 86 0.8× 26 1.1k
Anna Kwilas United States 16 240 0.8× 95 0.5× 587 3.3× 246 2.2× 106 1.0× 24 969
Ari Itoh‐Nakadai Japan 16 340 1.2× 64 0.3× 86 0.5× 71 0.6× 56 0.5× 22 861
L. Stievano Italy 11 179 0.6× 75 0.4× 234 1.3× 66 0.6× 82 0.8× 16 493
I G Schmidt-Wolf Germany 13 190 0.7× 83 0.4× 653 3.6× 79 0.7× 76 0.7× 24 1.0k
Elisabetta Dondi France 15 218 0.8× 73 0.4× 256 1.4× 55 0.5× 42 0.4× 34 723
Kiyoto Takehara Japan 12 134 0.5× 98 0.5× 153 0.9× 134 1.2× 41 0.4× 41 622

Countries citing papers authored by Benjamin Verret

Since Specialization
Citations

This map shows the geographic impact of Benjamin Verret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Verret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Verret more than expected).

Fields of papers citing papers by Benjamin Verret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Verret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Verret. The network helps show where Benjamin Verret may publish in the future.

Co-authorship network of co-authors of Benjamin Verret

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Verret. A scholar is included among the top collaborators of Benjamin Verret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Verret. Benjamin Verret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vanacker, Hélène, Nicolas Penel, Sarah Watson, et al.. (2025). Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study. Cancer. 131(18). e70052–e70052. 1 indexed citations
2.
Assi, Tarek, Carine Ngo, Matthieu Faron, et al.. (2025). Therapeutic advances in Tenosynovial giant cell Tumor: Targeting the CSF1/CSF1R axis. Cancer Treatment Reviews. 134. 102904–102904. 1 indexed citations
3.
4.
Sandoval, Renata Lazari, Michele Bottosso, Tianyu Li, et al.. (2024). TP53-associated early breast cancer: new observations from a large cohort. JNCI Journal of the National Cancer Institute. 116(8). 1246–1254. 6 indexed citations
5.
Bottosso, Michele, Benjamin Verret, Olivier Caron, et al.. (2024). Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome. JCO Precision Oncology. 8(8). e2400139–e2400139. 3 indexed citations
6.
Bottosso, Michele, Renata Lazari Sandoval, Benjamin Verret, et al.. (2024). HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome. European Journal of Cancer. 211. 114307–114307. 1 indexed citations
7.
Penel, Nicolas, Sylvie Bonvalot, Marie‐Cécile Le Deley, et al.. (2023). Pain in desmoid‐type fibromatosis: Prevalence, determinants and prognosis value. International Journal of Cancer. 153(2). 407–416. 8 indexed citations
8.
Faron, Matthieu, Olivier Mir, Antonin Lévy, et al.. (2023). Intraoperative motive for incomplete resection in primary retroperitoneal sarcoma. Progrès en Urologie. 33(15-16). 1026–1032. 1 indexed citations
9.
Malka, David, Benjamin Verret, Matthieu Faron, et al.. (2023). Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trial. European Journal of Cancer. 195. 113400–113400. 2 indexed citations
10.
Assi, Tarek, Carine Ngo, Matthieu Faron, et al.. (2023). Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review. Current Treatment Options in Oncology. 24(11). 1598–1613. 1 indexed citations
11.
Mateus, Christine, et al.. (2023). Contribution of collegial support meetings (CSM) in the management of complex situations of patients with advanced cancer. Supportive Care in Cancer. 31(6). 329–329. 2 indexed citations
12.
Cousin, Sophie, Carine Bellera, Thibaud Valentin, et al.. (2023). 1920MO Regomune: A phase II study of regorafenib + avelumab in solid tumors - Results of the advanced or metastatic gastrointestinal stromal tumors (mGIST) cohort. Annals of Oncology. 34. S1033–S1033. 2 indexed citations
13.
14.
Honoré, Charles, Matthieu Faron, Andréa Cavalcanti, et al.. (2021). Prospective evaluation of intensity-modulated radiotherapy toxicity in extremity soft tissue sarcomas patients: A role for irradiated healthy soft tissue volume?. Clinical and Translational Radiation Oncology. 29. 79–84. 4 indexed citations
15.
Assi, Tarek, Joseph Kattan, Elie Rassy, et al.. (2021). Chemotherapy in the management of periosteal osteosarcoma: A narrative review. Journal of bone oncology. 30. 100389–100389. 13 indexed citations
16.
Carton, Matthieu, Luc Cabel, Anne Patsouris, et al.. (2020). 281MO Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database. Annals of Oncology. 31. S353–S353. 2 indexed citations
17.
Verret, Benjamin, Cécile Badoual, Pierre Combe, A. Carlotti, & Stéphane Oudard. (2016). Targeted Therapy’s Skin Toxicities after Immunotherapy: Skin Toxicity of Tyrosine Kinase Inhibitor Therapy Following Nilovumab Therapy for Metastatic Renal Cell Carcinoma. 1(1). 1 indexed citations
18.
Verret, Benjamin, Charles Honoré, Sarah Dumont, et al.. (2016). Trabectedin in advanced desmoplastic round cell tumors. Anti-Cancer Drugs. 28(1). 116–119. 9 indexed citations
19.
Verret, Benjamin, Stéphane Oudard, Aurore Vozy, & Suzette Delaloge. (2016). Brèves de l’AERIO. ONCOLOGIE. 18(1). 76–80.
20.
Verret, Benjamin. (2012). Intérêts d’une intervention précoce des soins palliatifs dans le cancer bronchique non à petite cellule métastatique. Douleurs Évaluation - Diagnostic - Traitement. 13(2). 106–107.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeannine Lacroix Breakdown of academic impact, for papers by Elizabeth Mroczek‐Musulman Breakdown of academic impact, for papers by Ursula R. Sorg Breakdown of academic impact, for papers by M L Veronese Breakdown of academic impact, for papers by Anna Kwilas Breakdown of academic impact, for papers by Ari Itoh‐Nakadai Breakdown of academic impact, for papers by L. Stievano Breakdown of academic impact, for papers by I G Schmidt-Wolf Breakdown of academic impact, for papers by Elisabetta Dondi Breakdown of academic impact, for papers by Kiyoto Takehara
Rankless by CCL
2026